Feed for /2005/related/proposals/ab269 PDF
LRB-0910/1
CTS:cmh:rs
2005 - 2006 LEGISLATURE
March 28, 2005 - Introduced by Representatives Wieckert, Musser, Gronemus,
Krawczyk, Vos, Van Roy, Pettis, Gard, Kreibich, Gielow, Underheim,
Berceau, Townsend, Albers, Hines, Bies, Ott, Shilling, Petrowski, Vrakas,
Mursau, Owens, Gunderson, Pridemore
and Molepske, cosponsored by
Senators Roessler, A. Lasee and Brown. Referred to Committee on Health.
AB269,1,2 1An Act to amend 450.11 (1); and to create 450.11 (4) (a) 8. and 450.11 (4m) of
2the statutes; relating to: prescription drug labels.
Analysis by the Legislative Reference Bureau
Current law requires prescription drug labels to specify certain information,
including the name and address of the practitioner who prescribed the drug, the date
on which the prescription was dispensed, the name of the patient, and directions for
the use of the drug product or device.
This bill requires prescription drug labels to specify, in addition to the above
information, the symptom or purpose for which the drug is being prescribed if the
patient wants the symptom or purpose to appear on the label. The practitioner who
prescribes the drug must ask the patient if the patient wants the symptom or purpose
to appear on the label. If the patient wants that information on the label, the
practitioner must add that information to the prescription order and the pharmacist
must include that information on the prescription drug label.
The people of the state of Wisconsin, represented in senate and assembly, do
enact as follows:
AB269, s. 1 3Section 1. 450.11 (1) of the statutes is amended to read:
AB269,2,74 450.11 (1) Dispensing. No person may dispense any prescribed drug or device
5except upon the prescription order of a practitioner. All prescription orders shall

1specify the date of issue, the name and address of the patient, the name and address
2of the practitioner, the name and quantity of the drug product or device prescribed,
3directions for the use of the drug product or device, the symptom or purpose for which
4the drug is being prescribed if required under sub. (4) (a) 8.,
and, if the order is
5written by the practitioner, the signature of the practitioner. Any oral prescription
6order shall be immediately reduced to writing by the pharmacist and filed according
7to sub. (2).
AB269, s. 2 8Section 2. 450.11 (4) (a) 8. of the statutes is created to read:
AB269,2,109 450.11 (4) (a) 8. The symptom or purpose for which the drug is being prescribed
10if the prescription order specifies the symptom or purpose under sub. (4m).
AB269, s. 3 11Section 3. 450.11 (4m) of the statutes is created to read:
AB269,2,1612 450.11 (4m) Label options. Before making a prescription order, a practitioner
13shall ask the patient if the patient wants the symptom or purpose for the prescription
14to be disclosed on the label. If the patient wants the symptom or purpose for the
15prescription to be disclosed on the label, the practitioner shall specify the symptom
16or purpose in the prescription order.
AB269, s. 4 17Section 4. Initial applicability.
AB269,2,1918 (1) The treatment of section 450.11 (4m) of the statutes first applies to
19prescription orders that are made on the effective day of this subsection.
AB269, s. 5 20Section 5. Effective date.
AB269,2,2221 (1) This act takes effect on the first day of the 6th month beginning after
22publication.
AB269,2,2323 (End)
Loading...
Loading...